Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Acquires Spectral Genomics to Grow Molecular Medicine, Genetic Screening Plays

NEW YORK, May 1 (GenomeWeb News) - PerkinElmer today said it has acquired Spectral Genomics for an undisclosed sum.

 

Privately held Spectral Genomics develops array comparative genome hybridization products and analysis software that enable researchers to identify chromosomal abnormalities related to cancer and pre- and post-natal genetic disorders.

 

Robert Friel, president of PerkinElmer's Life and Analytical Sciences, said Spectral Genomics' technologies are "highly complementary to our current molecular medicine and genetic screening offerings."

 

Terms and other details of the deal were not disclosed.